文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

体外二氧化碳清除治疗哮喘持续状态

Extracorporeal Carbon Dioxide Removal in the Treatment of Status Asthmaticus.
PubMed 文献 · Crit Care Med · 2020-01-01
一句话结论回顾性系列中,26例哮喘持续状态患者接受静脉-静脉体外二氧化碳清除后24小时血气、气道压、内源性呼气末正压及升压药使用均改善,存活出院率100%。

该研究为医学ICU的回顾性综述,纳入26例接受静脉-静脉体外二氧化碳清除的成人哮喘持续状态患者。启动体外二氧化碳清除后24小时,动脉血气、峰值气道压、内源性呼气末正压及升压药使用均显著改善。存活出院率100%,20例(76.9%)在体外二氧化碳清除支持下成功拔管且无一例再插管。最常见并发症为导管相关深静脉血栓(6例,23.1%),4例(15.4%)出血需输注浓缩红细胞。作者结论认为该支持可作为挽救手段直至加重期缓解,部分患者早期拔管安全可行。

要点

  • 26例成人哮喘持续状态患者接受静脉-静脉体外二氧化碳清除,存活出院率100%。
  • 启动体外二氧化碳清除后24小时血气值显著改善,峰值气道压、内源性呼气末正压及升压药使用亦改善。
  • 20例(76.9%)在体外二氧化碳清除支持下成功拔管,无一例需再插管。
  • 最常见并发症为导管相关深静脉血栓(6例,23.1%);4例(15.4%)出血需输注浓缩红细胞。
  • 作者认为在部分接受体外二氧化碳清除的患者中早期拔管安全可行,可避免正压机械通气的不良影响。

适用人群与场景

  • 医学ICU中接受静脉-静脉体外二氧化碳清除治疗的26例成人哮喘持续状态患者。

研究设计与关键结果

  • 回顾性综述,纳入26例成人哮喘持续状态患者,接受静脉-静脉体外二氧化碳清除,无干预对照。
  • 启动体外二氧化碳清除后24小时血气值显著改善,峰值气道压、内源性呼气末正压及升压药使用亦改善。
  • 存活出院率100%;20例(76.9%)在体外二氧化碳清除支持下成功拔管,无一例再插管。
  • 最常见并发症为导管相关深静脉血栓(6例,23.1%);4例(15.4%)出血需输注浓缩红细胞。

证据类型、等级与局限

  • 证据类型:回顾性综述(医学ICU单中心系列,原文未报告中心数)。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,静脉-静脉体外二氧化碳清除可作为哮喘持续状态患者的挽救性支持手段,直至加重期缓解,并发症发生率可接受。
  • 作者认为,在部分接受体外二氧化碳清除的患者中早期拔管安全可行,可避免正压机械通气的不良影响。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Venovenous extracorporeal carbon dioxide removal may be lifesaving in the setting of status asthmaticus.

DESIGN: Retrospective review.

SETTING: Medical ICU.

PATIENTS: Twenty-six adult patients with status asthmaticus treated with venovenous extracorporeal carbon dioxide removal.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Demographic data and characteristics of current and prior asthma treatments were obtained from the electronic medical record. Mechanical ventilator settings, arterial blood gases, vital signs, and use of vasopressors were collected from the closest time prior to cannulation and 24 hours after initiation of extracorporeal carbon dioxide removal. Extracorporeal carbon dioxide removal settings, including blood flow and sweep gas flow, were collected at 24 hours after initiation of extracorporeal carbon dioxide removal. Outcome measures included rates of survival to hospital discharge, ICU and hospital lengths of stay, duration of invasive mechanical ventilation and extracorporeal carbon dioxide removal support, and complications during extracorporeal carbon dioxide removal. Following the initiation of extracorporeal carbon dioxide removal, blood gas values were significantly improved at 24 hours, as were peak airway pressures, intrinsic positive end-expiratory pressure, and use of vasopressors. Survival to hospital discharge was 100%. Twenty patients (76.9%) were successfully extubated while receiving extracorporeal carbon dioxide removal support; none required reintubation. The most common complication was cannula-associated deep venous thrombosis (six patients, 23.1%). Four patients (15.4%) experienced bleeding that required a transfusion of packed RBCs.

CONCLUSIONS: In the largest series to date, use of venovenous extracorporeal carbon dioxide removal in patients with status asthmaticus can provide a lifesaving means of support until the resolution of the exacerbation, with an acceptably low rate of complications. Early extubation in select patients receiving extracorporeal carbon dioxide removal is safe and feasible and avoids the deleterious effects of positive-pressure mechanical ventilation in this patient population.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Bromberger BJ, Agerstrand C, Abrams D, et al. Extracorporeal Carbon Dioxide Removal in the Treatment of Status Asthmaticus. Crit Care Med. 2020. PMID: 33031151. doi:10.1097/CCM.0000000000004645

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。